Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jan 7, 2024; 30(1): 79-90
Published online Jan 7, 2024. doi: 10.3748/wjg.v30.i1.79
Table 4 Univariate analysis of severe complications after laparoscopic total gastrectomy in gastric cancer patients
Variate
No-severe complication (%)
Severe complication (%)
t/χ2
P value
OR
95%CI
Age group
Age < 65332304.3810.036
Age ≥ 65181291.7331.032-3.047
Gender
Male372440.1130.736
Female141150.8990.485-1.667
BMI group
BMI ≤ 28481531.3190.251
BMI > 283261.7020.680-4.257
Hb129.1 ± 25.1135.2 ± 25.7-1.7540.081.010.999-1.021
ALB40.4 ± 3.139.7 ± 3.21.6640.0970.9280.851-1.013
Tumor size4.0 ± 2.23.8 ± 1.90.6740.5010.950.826-1.092
Bleeding volume150.2 ± 133.5130.2 ± 70.01.1140.2550.9980.995-1.001
Operative time248.9 ± 73.9229.0 ± 62.51.9830.0480.9960.991-1.000
Intraoperative blood transfusion37.1 ± 180.810.17 ± 54.8{0.099}0.7540.9980.995-1.002
Severe heart disease
No512590.1150.734
Yes10
Severe lung disease
No5115613.461< 0.001
Yes2313.6872.239-83.665
Hypertension
No452491.2450.264
Yes61101.5120.728-3.140
Diabetes
No489533.210.073
Yes2462.3070.902-5.896
Surgerical type
totally230354.4670.035
assisted283240.5570.322-0.964
ECOG
04263422.379< 0.001
177213.4171.883-6.199
21045.0121.493-16.824
ASA
25055128.024< 0.001
3889.9023.566-27.499